Observations from ID and Beyond: Leaked Remdesivir Study Information, Tocilizumab and Sarilumab Trials, and the Hazards of Early COVID-19 Research Findings

In HIV and ID Observations, Dr. Paul Sax examines how rapidly scientific information for the COVID-19 pandemic is being released to the public.

Information about the COVID-19 pandemic is being rapidly released to the public — often without peer review and sometimes even just based on a screenshot of a study. Dr. Paul Sax discusses what we actually do know about some of the treatments under investigation in the latest HIV and ID Observations blog post.

Want to see more from NEJM Journal Watch? Register here.

Observations from ID and Beyond: Leaked Remdesivir Study Information, Tocilizumab and Sarilumab Trials, and the Hazards of Early COVID-19 Research Findings

Topics